Loading...
Back to narrative

Update shared on16 Sep 2025

Fair value Increased 2.17%
AnalystConsensusTarget's Fair Value
AU$82.51
12.0% overvalued intrinsic discount
16 Sep
AU$92.43
Loading
1Y
30.9%
7D
-0.4%

The upward revision in Wesfarmers’ price target is primarily supported by modest improvements in both consensus revenue growth forecasts and future P/E multiples, resulting in a fair value increase to A$82.51.


What's in the News


  • Wesfarmers announced a proposed capital management initiative totalling $1.50 per share, expected to include a $1.10 per share capital component and a $0.40 per share fully-franked special dividend, pending ATO approval.
  • A fully franked dividend of AUD 1.11 per share was declared for the six months ended June 30, 2025.

Valuation Changes


Summary of Valuation Changes for Wesfarmers

  • The Consensus Analyst Price Target has risen slightly from A$80.76 to A$82.51.
  • The Consensus Revenue Growth forecasts for Wesfarmers has risen slightly from 4.1% per annum to 4.3% per annum.
  • The Future P/E for Wesfarmers has risen slightly from 33.53x to 34.24x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.